These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8361538)

  • 1. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition.
    Jacenko O; LuValle PA; Olsen BR
    Nature; 1993 Sep; 365(6441):56-61. PubMed ID: 8361538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retarded skeletal development in transgenic mice with a type II collagen mutation.
    Savontaus M; Metsranta M; Vuorio E
    Am J Pathol; 1996 Dec; 149(6):2169-82. PubMed ID: 8952549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chicken collagen X regulatory sequences restrict transgene expression to hypertrophic cartilage in mice.
    Campbell MR; Gress CJ; Appleman EH; Jacenko O
    Am J Pathol; 2004 Feb; 164(2):487-99. PubMed ID: 14742255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia.
    Warman ML; Abbott M; Apte SS; Hefferon T; McIntosh I; Cohn DH; Hecht JT; Olsen BR; Francomano CA
    Nat Genet; 1993 Sep; 5(1):79-82. PubMed ID: 8220429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain.
    Metsäranta M; Garofalo S; Decker G; Rintala M; de Crombrugghe B; Vuorio E
    J Cell Biol; 1992 Jul; 118(1):203-12. PubMed ID: 1618904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dominant negative mutation in the alpha 1 (X) collagen gene produces spondylometaphyseal defects in mice.
    Jacenko O; LuValle P; Solum K; Olsen BR
    Prog Clin Biol Res; 1993; 383B():427-36. PubMed ID: 8115362
    [No Abstract]   [Full Text] [Related]  

  • 7. Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation.
    Barbieri O; Astigiano S; Morini M; Tavella S; Schito A; Corsi A; Di Martino D; Bianco P; Cancedda R; Garofalo S
    Am J Physiol Cell Physiol; 2003 Dec; 285(6):C1504-12. PubMed ID: 12917109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function.
    Kwan KM; Pang MK; Zhou S; Cowan SK; Kong RY; Pfordte T; Olsen BR; Sillence DO; Tam PP; Cheah KS
    J Cell Biol; 1997 Jan; 136(2):459-71. PubMed ID: 9015315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type Schmid.
    Ho MS; Tsang KY; Lo RL; Susic M; Mäkitie O; Chan TW; Ng VC; Sillence DO; Boot-Handford RP; Gibson G; Cheung KM; Cole WG; Cheah KS; Chan D
    Hum Mol Genet; 2007 May; 16(10):1201-15. PubMed ID: 17403716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking hematopoiesis to endochondral skeletogenesis through analysis of mice transgenic for collagen X.
    Jacenko O; Roberts DW; Campbell MR; McManus PM; Gress CJ; Tao Z
    Am J Pathol; 2002 Jun; 160(6):2019-34. PubMed ID: 12057907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia.
    Zabel B; Hilbert K; Stöss H; Superti-Furga A; Spranger J; Winterpacht A
    Am J Med Genet; 1996 May; 63(1):123-8. PubMed ID: 8723097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of Col11a2 produces a mild cartilage phenotype in transgenic mice: comparison with the human disorder otospondylomegaepiphyseal dysplasia (OSMED).
    Li SW; Takanosu M; Arita M; Bao Y; Ren ZX; Maier A; Prockop DJ; Mayne R
    Dev Dyn; 2001 Oct; 222(2):141-52. PubMed ID: 11668593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fourier transform infrared microspectroscopic analysis identifies alterations in mineral properties in bones from mice transgenic for type X collagen.
    Paschalis EP; Jacenko O; Olsen B; Mendelsohn R; Boskey AL
    Bone; 1996 Aug; 19(2):151-6. PubMed ID: 8853859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-position collagen II mutation disrupts cartilage formation and skeletal development in a transgenic mouse model of spondyloepiphyseal dysplasia.
    Gaiser KG; Maddox BK; Bann JG; Boswell BA; Keene DR; Garofalo S; Horton WA
    J Bone Miner Res; 2002 Jan; 17(1):39-47. PubMed ID: 11771668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonsense mutation in the carboxyl-terminal domain of type X collagen causes haploinsufficiency in schmid metaphyseal chondrodysplasia.
    Chan D; Weng YM; Graham HK; Sillence DO; Bateman JF
    J Clin Invest; 1998 Apr; 101(7):1490-9. PubMed ID: 9525992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed synthesis of type II collagen interferes with rate of bone formation and growth and increases bone resorption in transgenic mice.
    Nieminen J; Sahlman J; Hirvonen T; Lapveteläinen T; Miettinen M; Arnala I; Malluche HH; Helminen HJ
    Calcif Tissue Int; 2008 Mar; 82(3):229-37. PubMed ID: 18297226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craniofacial abnormalities in mice carrying a dominant interference mutation in type X collagen.
    Chung KS; Jacenko O; Boyle P; Olsen BR; Nishimura I
    Dev Dyn; 1997 Apr; 208(4):544-52. PubMed ID: 9097026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and biochemical consequences of collagen X mutations in mice and humans.
    Chan D; Jacenko O
    Matrix Biol; 1998 Jul; 17(3):169-84. PubMed ID: 9707340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, in cartilage, of a 7-amino-acid deletion in type II collagen from two unrelated individuals with Kniest dysplasia.
    Bogaert R; Wilkin D; Wilcox WR; Lachman R; Rimoin D; Cohn DH; Eyre DR
    Am J Hum Genet; 1994 Dec; 55(6):1128-36. PubMed ID: 7977371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification.
    Hattori T; Müller C; Gebhard S; Bauer E; Pausch F; Schlund B; Bösl MR; Hess A; Surmann-Schmitt C; von der Mark H; de Crombrugghe B; von der Mark K
    Development; 2010 Mar; 137(6):901-11. PubMed ID: 20179096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.